Cargando…

Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding

Using computer algorithms and commercial DNA synthesis, one or more ORFs of a microbial pathogen such as a virus can be recoded and deoptimized by several strategies that may involve the introduction of up to thousands of nucleotide (nt) changes without affecting amino acid (aa) coding. The synonymo...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Nouën, Cyril, Collins, Peter L., Buchholz, Ursula J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558635/
https://www.ncbi.nlm.nih.gov/pubmed/31231383
http://dx.doi.org/10.3389/fimmu.2019.01250
_version_ 1783425667838246912
author Le Nouën, Cyril
Collins, Peter L.
Buchholz, Ursula J.
author_facet Le Nouën, Cyril
Collins, Peter L.
Buchholz, Ursula J.
author_sort Le Nouën, Cyril
collection PubMed
description Using computer algorithms and commercial DNA synthesis, one or more ORFs of a microbial pathogen such as a virus can be recoded and deoptimized by several strategies that may involve the introduction of up to thousands of nucleotide (nt) changes without affecting amino acid (aa) coding. The synonymous recoding strategies that have been applied to RNA viruses include: deoptimization of codon or codon-pair usage, which may reduce protein expression among other effects; increased content of immunomodulatory CpG and UpA RNA, which increase immune responses and thereby restrict viral replication; and substitution of serine and leucine codons with synonymous codons for which single-nt substitutions can yield nonsense codons, thus limiting evolutionary potential. This can reduce pathogen fitness and create potential live-attenuated vaccines that may have improved properties. The combined approach of genome recoding, synthetic biology, and reverse genetics offers several advantages for the generation of attenuated RNA viruses. First, synonymous recoding involves many mutations, which should reduce the rate and magnitude of de-attenuation. Second, increasing the amount of recoding can provide increased attenuation. Third, because there are no changes at the aa level, all of the relevant epitopes should be expressed. Fourth, attenuation frequently does not compromise immunogenicity, suggesting that the recoded viruses have increased immunogenicity per infectious particle. Synonymous deoptimization approaches have been applied to two important human viral pathogens, namely respiratory syncytial virus (RSV) and influenza A virus (IAV). This manuscript will briefly review the use of these different methods of synonymous recoding to generate attenuated RSV and IAV strains. It also will review the characterization of these vaccine candidates in vitro and in animal models, and describe several surprising findings with respect to phenotypic and genetic instability of some of these candidates.
format Online
Article
Text
id pubmed-6558635
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65586352019-06-21 Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding Le Nouën, Cyril Collins, Peter L. Buchholz, Ursula J. Front Immunol Immunology Using computer algorithms and commercial DNA synthesis, one or more ORFs of a microbial pathogen such as a virus can be recoded and deoptimized by several strategies that may involve the introduction of up to thousands of nucleotide (nt) changes without affecting amino acid (aa) coding. The synonymous recoding strategies that have been applied to RNA viruses include: deoptimization of codon or codon-pair usage, which may reduce protein expression among other effects; increased content of immunomodulatory CpG and UpA RNA, which increase immune responses and thereby restrict viral replication; and substitution of serine and leucine codons with synonymous codons for which single-nt substitutions can yield nonsense codons, thus limiting evolutionary potential. This can reduce pathogen fitness and create potential live-attenuated vaccines that may have improved properties. The combined approach of genome recoding, synthetic biology, and reverse genetics offers several advantages for the generation of attenuated RNA viruses. First, synonymous recoding involves many mutations, which should reduce the rate and magnitude of de-attenuation. Second, increasing the amount of recoding can provide increased attenuation. Third, because there are no changes at the aa level, all of the relevant epitopes should be expressed. Fourth, attenuation frequently does not compromise immunogenicity, suggesting that the recoded viruses have increased immunogenicity per infectious particle. Synonymous deoptimization approaches have been applied to two important human viral pathogens, namely respiratory syncytial virus (RSV) and influenza A virus (IAV). This manuscript will briefly review the use of these different methods of synonymous recoding to generate attenuated RSV and IAV strains. It also will review the characterization of these vaccine candidates in vitro and in animal models, and describe several surprising findings with respect to phenotypic and genetic instability of some of these candidates. Frontiers Media S.A. 2019-06-04 /pmc/articles/PMC6558635/ /pubmed/31231383 http://dx.doi.org/10.3389/fimmu.2019.01250 Text en Copyright © 2019 Le Nouën, Collins and Buchholz. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Le Nouën, Cyril
Collins, Peter L.
Buchholz, Ursula J.
Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
title Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
title_full Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
title_fullStr Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
title_full_unstemmed Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
title_short Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding
title_sort attenuation of human respiratory viruses by synonymous genome recoding
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558635/
https://www.ncbi.nlm.nih.gov/pubmed/31231383
http://dx.doi.org/10.3389/fimmu.2019.01250
work_keys_str_mv AT lenouencyril attenuationofhumanrespiratoryvirusesbysynonymousgenomerecoding
AT collinspeterl attenuationofhumanrespiratoryvirusesbysynonymousgenomerecoding
AT buchholzursulaj attenuationofhumanrespiratoryvirusesbysynonymousgenomerecoding